NCT04756726
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04756726
Title Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors C4 Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
University of California-San Francisco San Francisco California 94143 United States Details
Colorado Blood Cancer Institute (Sarah Cannon Research Institute) Denver Colorado 80218 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Emory University Hospital Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University School of St. Louis St Louis Missouri 63110 United States Details
Mt Sinai Medical Center New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Tennessee Oncology (Sarah Cannon Research Institute) Nashville Tennessee 37203 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field